Olanzapine versus risperidone in the treatment of post-psychotic depression in schizophrenic patients

被引：27

作者：

Dollfus, S

Olivier, W

Chabot, B

Déal, C

Perrin, E

机构：

[1] Ctr Hosp & Univ, Dept Psychiat, Ctr Esquirol, F-14000 Caen, France

[2] Lilly France, Dept Neurosci, F-91258 Suresnes, France

来源：

SCHIZOPHRENIA RESEARCH | 2005年 / 78卷 / 2-3期

关键词：

schizophrenia; post-psychotic depression; atypical antipsychotics;

D O I：

10.1016/j.schres.2005.06.001

中图分类号：

R749 [精神病学];

学科分类号：

100205 [精神病与精神卫生学];

摘要：

Objective: To compare the efficacy of two atypical antipsychotic drugs, olanzapine and risperidone, in schizophrenic patients with post-psychotic depression. Results: A clinically significant decrease of MADRS scores occurred in patients treated with both drugs for 8 weeks. Conclusion: Atypical antipsychotic drugs may be particularly appropriate when treating schizophrenic patients with depression. (c) 2005 Elsevier B.V All rights reserved.

引用

页码：157 / 159

页数：3

共 7 条

[1]

Clinical issues related to depression in schizophrenia: an international survey of psychiatrists [J].